The clinical leads for the pathology workstream were appointed on 7th March 2018 and endorsed by the Royal College of Pathologists. You can read more about the appointment of the clinical leads here.
Joint Clinical Lead: Simon Knowles
Simon has worked in academic, public sector and commercial pathology in the UK and Australia, first as a fetal and perinatal pathologist and latterly as a cellular pathologist. He was director of laboratory services for the Women’s Hospital in Western Australia and led the cervical screening service for Somerset and West Dorset.
For the last decade, Simon has been actively engaged in clinical quality improvement, in the UK and Africa. Previously a non-executive director on a clinical commissioning group, he is now a non-executive director on the board of the Royal Devon & Exeter NHS Foundation Trust. He is the Immediate Past President of the Association of Clinical Pathologists and continues to write for the ACP News, which he used to edit. His major interest is in how laboratory medicine contributes to patient experience and clinical outcome.
Joint Clinical Lead: Tom Lewis
Following a degree in Natural Sciences, Tom obtained a PhD in cancer research, before studying medicine in the West Midlands. He has published on a variety of topics, from assessment of hospital cleaning to the first description of using whole genome sequencing of MDR-Acinetobacter to study a hospital outbreak.
Tom was appointed as Consultant Microbiologist at North Devon Healthcare NHS Trust in 2010. As lead clinician for Antibiotic Stewardship, he has been involved in a number of interventions to improve prescribing habits, focusing in particular on the behavioural science behind this. Over the last few years, he has been particularly interested in how pathology can be used to redesign health systems. Working closely with colleagues in primary and secondary care, they have shown that paying attention to the needs of the patient is an effective way to improve quality and reduce costs. Laboratory data, linked with clinical stories, has been the keystone for building engagement with clinicians.
Joint Clinical Lead: Marion Wood
Marion has been a Consultant Clinical and Laboratory Haematologist for 25 years. Following a short spell in a specialist Haemostasis & Thrombosis unit, she has been entirely based in a district general hospital. The laboratory service was recently part of the East of England Pathology Partnership, with which Marion took on a part time management role and thus has first-hand experience of the challenges of networking.
Alongside her clinical work, Marion has undertaken several other management roles at local, regional and national level. These have included Deputy Medical Director and Medical Director at Colchester University Hospital NHS Foundation Trust, current Chair of Council of the Association of Clinical Pathologists and a member of the Pathology Alliance. She is looking forward to bringing her skills and experience to work as part of the GIRFT Pathology team.
Clinical Advisor: Dr Martin Myers MBE
Dr Myers is a Consultant Clinical Biochemist at Lancashire Teaching Hospitals NHS Foundation Trust (LTH), Royal Preston Hospital, and Associate Divisional Medical Director for Pathology, having previously been Clinical Director of Pathology for 14 years. Dr Myers is also the Lead Scientist for the Trust.
Dr Myers has taken a lead role in a continuous program of Pathology re-design, improving the clinical and operational effectiveness of Pathology delivery whilst improving productivity. His interests include the use of automation, point of care testing and informatics in improving the quality of the diagnostic process and redesigning pathology delivery. This spans pathology delivery using state of the art robotics and advanced technology through to the use of point of care devices used anywhere. He chairs the Trust Point of Care Testing Committee. The “Laboratory Anywhere” concept including “Lab in a Box” models delivers diagnostics in a variety of locations both inside and outside the hospital ensuring that diagnostics are embedded in the patient pathway, rather than remote from the patient. He is involved in several projects for the direct delivery of diagnostics to BAME communities and vulnerable groups and is working with the NHSE Chief Scientific Officer’s team on the delivery of point of care diagnostics in patients with Learning Difficulties and patients experiencing Mental Health issues. He has also been involved in translating NICE diagnostic recommendations into service delivery models.
Dr Myers has worked on many clinical pathways where the introduction of novel decision diagnostics has improved the patient pathway and resulted in reduction in total pathway costs.